Dr. Brent Fogel

Posted on April 20, 2017

Dr. Brent Fogel, associate professor of neurology and human genetics at the David Geffen School of Medicine at UCLA and director of the UCLA Neurogenetics Clinic, commented April 14 in a Los Angeles Times story about the newly FDA-approved 23AndMe genetic health risk tests.